| __timestamp | Evotec SE | Opthea Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 12404000 | 3401685 |
| Thursday, January 1, 2015 | 18343000 | 4284228 |
| Friday, January 1, 2016 | 18108000 | 3581295 |
| Sunday, January 1, 2017 | 17614000 | 4838300 |
| Monday, January 1, 2018 | 35619000 | 24891534 |
| Tuesday, January 1, 2019 | 58432000 | 31347891 |
| Wednesday, January 1, 2020 | 63945000 | 17480747 |
| Friday, January 1, 2021 | 72200000 | 34710152 |
| Saturday, January 1, 2022 | 76642000 | 108459978 |
| Sunday, January 1, 2023 | 57519000 | 181563523 |
| Monday, January 1, 2024 | 176326321 |
Data in motion
In the ever-evolving landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Opthea Limited and Evotec SE, two prominent players in the field, have demonstrated varying levels of investment in R&D over the past decade.
From 2014 to 2023, Evotec SE's R&D expenses grew steadily, peaking in 2022 with a 518% increase from 2014. Opthea Limited, however, showcased a more dramatic rise, with a staggering 5,240% increase in R&D spending by 2023 compared to 2014. This surge underscores Opthea's aggressive push towards innovation, particularly in recent years.
While Evotec SE maintained a consistent upward trend, Opthea's spending in 2023 alone surpassed Evotec's peak by 137%. This data highlights Opthea's strategic focus on R&D, positioning it as a frontrunner in the race for innovation.
Research and Development: Comparing Key Metrics for AbbVie Inc. and Opthea Limited
Research and Development: Comparing Key Metrics for Genmab A/S and Evotec SE
Comparing Innovation Spending: Lantheus Holdings, Inc. and Opthea Limited
Comparing Innovation Spending: Opthea Limited and Protagonist Therapeutics, Inc.
Analyzing R&D Budgets: Opthea Limited vs Dynavax Technologies Corporation
Comparing Innovation Spending: Opthea Limited and Celldex Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Opthea Limited and BioCryst Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: PTC Therapeutics, Inc. vs Evotec SE
Research and Development Investment: Perrigo Company plc vs Evotec SE
R&D Insights: How Iovance Biotherapeutics, Inc. and Evotec SE Allocate Funds
Amphastar Pharmaceuticals, Inc. vs Evotec SE: Strategic Focus on R&D Spending
R&D Insights: How BioCryst Pharmaceuticals, Inc. and Evotec SE Allocate Funds